FDA Inspection 633841 — Armstrong Pharmaceuticals, Inc.
The FDA completed an inspection of Armstrong Pharmaceuticals, Inc. on December 11, 2009 in Canton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 11, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Canton, MA (United States)